Detalhe da pesquisa
1.
circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis.
Mol Cancer
; 21(1): 24, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045883
2.
HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1.
Int J Oncol
; 62(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825600
3.
Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer.
J Exp Clin Cancer Res
; 42(1): 324, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012734
4.
Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial.
Cancer Commun (Lond)
; 43(2): 257-275, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579790
5.
circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
J Exp Clin Cancer Res
; 41(1): 71, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189958
6.
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair.
Oncogene
; 41(16): 2372-2389, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264742
7.
A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer.
Aging (Albany NY)
; 13(9): 12493-12513, 2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901011
8.
Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-ß1/smad2/3 axis in pancreatic cancer.
Cancer Lett
; 459: 204-215, 2019 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199988
9.
Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-ß1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].
Cancer Lett
; 548: 215897, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050250